Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sanofi-Synthelabo (0) Acquired (5)
alfuzosin (uroxatral) (2003 NDA)
fondaparinux sodium (arixtra) (2001 NDA)
oxaliplatin (eloxatin) (2002 NDA)
rasburicase (elitek) (2002 NDA)
sarilumab (kevzara) (2017)
Key: Sanofi-Synthelabo (1) Acquired (185)
abiraterone (zytiga) (7 trials)
acetaminophen (tylenol) (10 trials)
acetylsalicylic acid (aspirin) (12 trials)
aciclovir (zovirax) (5 trials)
adefovir dipivoxil (hepsera) (1 trial)
agalsidase alfa (Replagal) (2 trials)
agalsidase beta (fabrazyme) (3 trials)
alemtuzumab (campath) (5 trials)
alfuzosin (uroxatral) (26 trials)
alglucosidase alfa (myozyme) (4 trials)
alirocumab (praluent) (51 trials)
amodiaquine (camoquin) (9 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (7 trials)
atenolol (tenormin) (2 trials)
atorvastatin (lipitor) (22 trials)
azathioprine (imuran) (1 trial)
azithromycin (zithromax) (7 trials)
benzoyl peroxide (clearasil) (2 trials)
bisacodyl (Halflytely) (2 trials)
bivalent oral polio vaccine (bopv), type 1 and type 3 (6 trials)
cabazitaxel (jevtana kit) (57 trials)
carboplatin (paraplatin) (54 trials)
cetirizine (zyrtec) (3 trials)
ciprofloxacin (cipro) (2 trials)
cisplatin (platinol) (70 trials)
clarithromycin (biaxin) (2 trials)
clindamycin (cleocin) (2 trials)
clopidogrel (plavix) (39 trials)
docetaxel (taxotere) (241 trials)
dronedarone (multaq) (17 trials)
dtap-ipv mkc vaccine (2 trials)
dupilumab (dupixent) (77 trials)
enoxaparin (lovenox) (41 trials)
enzalutamide (xtandi) (4 trials)
esomeprazole (nexium) (1 trial)
everolimus (zortress) (1 trial)
felodipine (plendil) (2 trials)
fenofibrate (fenoglide) (8 trials)
fexofenadine (allegra) (17 trials)
filgrastim (neupogen) (11 trials)
fluorouracil (efudex) (91 trials)
glatiramer acetate (copaxone) (5 trials)
glimepiride (amaryl) (22 trials)
glipizide (glucotrol) (1 trial)
glucagon-like peptide-1 (2 trials)
glyburide (micronase) (3 trials)
granisetron (kytril) (1 trial)
haloperidol (haldol) (1 trial)
heparin (liquaemin) (8 trials)
hydrochlorothiazide (esidrix) (12 trials)
hydroxychloroquine (plaquenil) (9 trials)
icosapent ethyl (vascepa) (3 trials)
imiglucerase (cerezyme) (3 trials)
inactivated hav vaccine, lu8 strain (1 trial)
inactivated hep a vaccine (1 trial)
inactivated influenza vaccine (88 trials)
insulin aspart (novolog) (7 trials)
insulin degludec (tresiba) (5 trials)
insulin detemir (Levemir) (5 trials)
insulin glargine (toujeo) (178 trials)
insulin glulisine (Apidra) (63 trials)
insulin human (humulin) (60 trials)
ketoprofen (orudis) (5 trials)
laronidase (aldurazyme) (1 trial)
leflunomide (arava) (9 trials)
leuprolide (lupron) (7 trials)
levofloxacin (levaquin) (4 trials)
levothyroxine (Synthroid) (3 trials)
liraglutide (victoza) (6 trials)
live attenuated varicella vaccine (5 trials)
live oral poliovirus type 1, 2 and 3 (1 trial)
lixisenatide (adlyxin) (48 trials)
loratadine (claritin) (3 trials)
lumefantrine (Coartem) (4 trials)
measles, mumps and rubella vaccine (3 trials)
menacwy conjugate vaccine (42 trials)
metformin (glucophage) (11 trials)
methylprednisolone (medrol) (7 trials)
metoclopramide (reglan) (1 trial)
metoprolol (lopressor) (4 trials)
metronidazole (flagyl) (1 trial)
mycophenolate (myfortic) (2 trials)
nateglinide (starlix) (1 trial)
olanzapine (zyprexa) (2 trials)
ondansetron (zofran) (2 trials)
oxaliplatin (eloxatin) (148 trials)
paliperidone (invega) (1 trial)
pioglitazone (actos) (7 trials)
plerixafor (mozobil) (14 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (10 trials)
poliovirus vaccine inactivated (8 trials)
polyene phosphatidylcholine (1 trial)
potassium iodide (thyro-block) (1 trial)
prasugrel (effient) (2 trials)
prednisone (meticorten) (38 trials)
pyrimethamine (daraprim) (1 trial)
rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (8 trials)
ranitidine (zantac) (12 trials)
rasburicase (elitek) (14 trials)
repaglinide (prandin) (2 trials)
risedronate (actonel) (32 trials)
risperidone (risperdal) (2 trials)
rosuvastatin (crestor) (15 trials)
sargramostim (leukine) (17 trials)
sarilumab (kevzara) (30 trials)
sitagliptin (januvia) (65 trials)
sulfasalazine (azulfidine) (4 trials)
tacrolimus (prograf) (5 trials)
telithromycin (ketek) (21 trials)
tenecteplase (tnkase) (2 trials)
teriflunomide (aubagio) (21 trials)
tetanus-diphtheria toxoid (3 trials)
tirofiban (aggrastat) (1 trial)
tofogliflozin hydrate (2 trials)
triamcinolone (kenalog) (7 trials)
valproic acid (depakene) (7 trials)
vancomycin (Vancocin) (1 trial)
Key: Sanofi-Synthelabo (2) Acquired (224)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)
adalimumab (humira) (2 trials)
aflibercept (zaltrap) (40 trials)
albiglutide (tanzeum) (1 trial)
allopurinol (zyloprim) (3 trials)
amiodarone (cordarone) (2 trials)
amlodipine (norvasc) (4 trials)
antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)
anti-inhibitor coagulant complex (activated prothrombin complex concentrate) (Autoplex-T) (1 trial)
antirabies serum (equine) (2 trials)
antithrombin iii (human) (thrombate iii) (1 trial)
avobenzone (shade uvaguard) (2 trials)
bevacizumab (avastin) (42 trials)
bicalutamide (casodex) (4 trials)
bifidobacterium longum (1 trial)
bivalent subtype c gp120 (1 trial)
bortezomib (velcade) (11 trials)
calcitriol (rocaltrol) (4 trials)
capecitabine (xeloda) (71 trials)
caplacizumab (cablivi) (2 trials)
carfilzomib (kyprolis) (4 trials)
c. difficile toxoid vaccine (2 trials)
cemiplimab (libtayo) (25 trials)
cetuximab (erbitux) (18 trials)
cetylpyridinium chloride (2 trials)
cholestyramine (questran) (6 trials)
ciclesonide (alvesco) (4 trials)
clobetasol (dermovate) (1 trial)
clofarabine (clolar) (2 trials)
coagulation factor ix (Recombinant) (Rixubis) (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cyclophosphamide (cytoxan) (34 trials)
dalfopristin (Synercid) (1 trial)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)
doxercalciferol (hectorol) (2 trials)
doxorubicin (Doxil) (24 trials)
dulaglutide (trulicity) (2 trials)
eliglustat (cerdelga) (6 trials)
empagliflozin (jardiance) (3 trials)
epirubicin (ellence) (15 trials)
eptifibatide (integrilin) (2 trials)
erlotinib (tarceva) (17 trials)
escitalopram (lexapro) (6 trials)
estramustine (emcyt) (5 trials)
ethambutol (myambutol) (2 trials)
etoposide (vepesid) (7 trials)
fedratinib (Inrebic) (10 trials)
finasteride (Proscar) (1 trial)
fludarabine (fludara) (5 trials)
fluocinolone acetonide (synalar) (1 trial)
fluticasone (cutivate) (7 trials)
fluvastatin (lescol) (5 trials)
fondaparinux sodium (arixtra) (3 trials)
gemcitabine (gemzar) (61 trials)
goserelin (zoladex) (2 trials)
hepatitis a vaccine, inactivated (vaqta) (5 trials)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
hepatitis b vaccine (recombinant) (recombivax) (4 trials)
hpv 16/18 vaccine (Cervarix) (2 trials)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
human rotavirus, live attenuated (Rotarix) (1 trial)
hydrocortisone (solu-cortef) (1 trial)
hylan g-f 20 (gz/sar402662) (1 trial)
inactivated japanese encephalitis vaccine (Ixiaro) (7 trials)
inactivated rabies vaccine (Imovax) (4 trials)
infanrix hexa vaccine (1 trial)
interferon beta-1b (betaseron) (1 trial)
ipilimumab (yervoy) (3 trials)
irinotecan (Camptosar) (42 trials)
Isatuximab (Sarclisa) (38 trials)
isoniazid (nydrazid) (3 trials)
ivermectin (stromectol) (5 trials)
lactobacillus paracasei (1 trial)
levocarnitine (carnitor) (1 trial)
live attenuated chimeric japanese encephalitis vaccine (6 trials)
live, attenuated, dengue serotype 1, 2, 3, 4 virus (11 trials)
live tetravalent chimeric dengue vaccine (15 trials)
lovastatin (mevacor) (2 trials)
measles, mumps, rubella, varicella vaccine (2 trials)
meningococcal a&c vaccine (2 trials)
migalastat (galafold) (1 trial)
mitoxantrone (novantrone) (4 trials)
modafinil (provigil) (1 trial)
mometasone (elocon) (5 trials)
montelukast (singulair) (4 trials)
moxifloxacin (avelox) (1 trial)
naltrexone (revia) (11 trials)
olipudase alfa (Xenpozyme) (4 trials)
omega-3 fatty acids (omacor) (2 trials)
omeprazole (prilosec) (8 trials)
paclitaxel (taxol) (20 trials)
palbociclib (ibrance) (2 trials)
peginterferon beta-1a (Plegridy) (5 trials)
pembrolizumab (keytruda) (8 trials)
pemetrexed (alimta) (11 trials)
phenprocoumon (liquamar) (1 trial)
phenylephrine (Prefrin) (1 trial)
piperacillin (pipracil) (1 trial)
pitavastatin (livalo) (3 trials)
pneumococcal 7-valent conjugate vaccine (prevnar) (2 trials)
pomalidomide (pomalyst) (7 trials)
pravastatin (pravachol) (5 trials)
prednisolone (hydeltra) (5 trials)
pyrazinamide (Aldinamide) (2 trials)
riferminogene pecaplasmid (6 trials)
rituximab (rituxan) (6 trials)
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent) (1 trial)
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent) (1 trial)
sevelamer (renagel) (5 trials)
simvastatin (zocor) (12 trials)
somatropin (protropin) (3 trials)
sorafenib (nexavar) (4 trials)
split virion influenza vaccine (1 trial)
spores of bacillus clausii (1 trial)
sutimlimab (Enjaymo) (1 trial)
tamoxifen (nolvadex) (1 trial)
telmisartan (micardis) (1 trial)
ticlopidine (ticlid) (2 trials)
tocilizumab (actemra) (3 trials)
topotecan (hycamtin) (6 trials)
trastuzumab (herceptin) (23 trials)
typhoid vi polysaccharide vaccine (Typhim Vi) (1 trial)
vinorelbine (navelbine) (14 trials)
warfarin (coumadin) (8 trials)
Key: Sanofi-Synthelabo (0) Acquired (172)
adenosine (Adenocard) (1 trial)
albumin iodinated i-131 serum (megatope) (1 trial)
albuterol (proventil) (2 trials)
aldesleukin (proleukin) (5 trials)
alvac melanoma multi-antigen therapeutic vaccine (1 trial)
apalutamide (erleada) (1 trial)
atezolizumab (tecentriq) (1 trial)
autologous mononuclear stem cell (1 trial)
bendamustine (treanda) (2 trials)
betamethasone (celestone) (1 trial)
bivalent cyd-1,3 dengue (1 trial)
bivalent cyd-2,4 dengue (1 trial)
budesonide (rhinocort) (2 trials)
celecoxib (celebrex) (1 trial)
clostridium difficile toxoids a and b (5 trials)
cobimetinib (cotellic) (1 trial)
coltuximab ravtansine (5 trials)
cromoglicic acid (Intal) (1 trial)
cytarabine (cytosar-u) (5 trials)
donepezil (aricept) (2 trials)
erythromycin (ilosone) (1 trial)
florbetapir (Amyvid) (1 trial)
fludeoxyglucose f-18 (1 trial)
formoterol (foradil) (2 trials)
fulvestrant (faslodex) (2 trials)
gvax prostate cancer vaccine (1 trial)
haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
hybrid 5 component dtap, vero ipv, hep b and prp-ompc (1 trial)
idarubicin (idamycin) (1 trial)
immune globulin (human) (2 trials)
interferon alpha-2a (roferon-a) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
levalbuterol (xopenex) (2 trials)
levoleucovorin (fusilev) (1 trial)
nolpitantium besylate (1 trial)
octreotide (sandostatin) (1 trial)
pegaspargase (oncaspar) (1 trial)
polymyxin b sulfate (poly-rx) (1 trial)
polysaccharide diphtheria conjugate vaccine (1 trial)
polysaccharide diphtheria toxoid conjugate vaccine (1 trial)
quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (6 trials)
ramucirumab (cyramza) (2 trials)
recombinant adenoviral human p53 gene (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
regadenoson (lexiscan) (1 trial)
reproterol hydrochloride (1 trial)
rifapentine (priftin) (4 trials)
rotavirus vaccine, live, oral, pentavalent (rotateq) (2 trials)
rubidium chloride rb-82 (1 trial)
serogroup b meningococcal vaccine (1 trial)
sildenafil (viagra) (2 trials)
smallpox vaccine, heat-stable freeze-dried powder, first generation (3 trials)
smallpox vaccine, lister strain (1 trial)
smallpox vaccine, tissue culture adapted jennerian (ACAM2000) (3 trials)
sp0202-vii pneumococcal conjugate vaccine (1 trial)
temozolomide (temodar) (5 trials)
timothy grass pollen allergen extract (Grastek) (1 trial)
tolterodine (detrol) (2 trials)
vasopressin v2 receptor antagonist (1 trial)
vincristine (oncovin) (1 trial)
Key: Sanofi-Synthelabo (0) Acquired (61)
acetylcholine chloride (miochol) (1 trial)
alendronic acid (fosamax) (1 trial)
crushed garlic clove (1 trial)
latanoprost (xalatan) (1 trial)
mefenamic acid (ponstel) (1 trial)
naphazoline (visine) (1 trial)
palonosetron (aloxi) (1 trial)
Key: Sanofi-Synthelabo (0) Acquired (22)
hydroxypropyltetrahydropyrantriol (1 trial)
ketoconazole (nizoral) (1 trial)
Adenocarcinoma (Phase 2)
Adenoma (Phase 3)
Alcohol Drinking (Phase 2)
Aortic Valve Stenosis (Phase 1)
Biliary Tract Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 3)
Constriction, Pathologic (Phase 1)
Coronary Artery Disease (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 3)
Digestive System Diseases (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Heart Failure (Phase 3)
Hyperplasia (Phase 3)
Lung Neoplasms (Phase 2)
Lupus Erythematosus, Systemic (Phase 4)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Malaria (Phase 3)
Malaria, Cerebral (Phase 3)
Mental Disorders (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neuralgia (Phase 3)
Pancreatic Neoplasms (Phase 2)
Parasomnias (Phase 2)
Prodromal Symptoms (Phase 4)
Prostatic Hyperplasia (Phase 3)
Prostatic Neoplasms (Phase 4)
Psychotic Disorders (Phase 4)
Recurrence (Phase 3)
Salivary Gland Neoplasms (Phase 2)
Schizophrenia (Phase 4)
Sleep Wake Disorders (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Thrombosis (Phase 4)
Urinary Bladder Neoplasms (Phase 2)